Aya Jakobovits

Senior Corporate Advisor at Bionaut Labs

Aya Jakobovits is an accomplished biotech executive with extensive track record in starting and growing biotech companies in the targeted immunotherapy area, based on novel technologies therapeutic products, including Founder and CEO of Adicet bio, Founding CEO of Kite Pharma (acquired by Gilead for $1.9B), CSO and SVP corporate development at Agensys and EVP and Head R&D at Astellas (acquired Agensys for $537M), Director and leader of XenoMouse technology at Cell Genesys/Abgenix (acquired by Amgen for $2.2B).


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Bionaut Labs

1 followers

Bionauts are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely.


Industries

Employees

11-50

Links